REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 188 filers reported holding REGENXBIO INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,516,000 | -79.2% | 46,369 | -73.3% | 0.02% | -76.9% |
Q3 2021 | $7,287,000 | -57.8% | 173,840 | -60.9% | 0.09% | -54.5% |
Q2 2021 | $17,286,000 | +100.3% | 444,939 | +75.9% | 0.20% | +102.0% |
Q1 2021 | $8,630,000 | -24.8% | 253,002 | 0.0% | 0.10% | -17.5% |
Q4 2020 | $11,476,000 | +185.5% | 253,002 | +73.3% | 0.12% | +150.0% |
Q3 2020 | $4,019,000 | -37.0% | 146,028 | -15.7% | 0.05% | -45.5% |
Q2 2020 | $6,379,000 | +16.6% | 173,192 | +2.5% | 0.09% | -5.4% |
Q1 2020 | $5,469,000 | -53.9% | 168,905 | -41.6% | 0.09% | -41.1% |
Q4 2019 | $11,852,000 | -73.2% | 289,281 | -76.7% | 0.16% | -71.7% |
Q3 2019 | $44,276,000 | -37.6% | 1,243,721 | -10.0% | 0.56% | -36.6% |
Q2 2019 | $71,007,000 | +93.8% | 1,382,262 | +116.3% | 0.88% | +106.6% |
Q1 2019 | $36,632,000 | +409.7% | 639,195 | +273.1% | 0.43% | +291.7% |
Q4 2018 | $7,187,000 | -14.5% | 171,326 | +53.9% | 0.11% | +53.5% |
Q3 2018 | $8,404,000 | +50.2% | 111,306 | +42.7% | 0.07% | +69.0% |
Q2 2018 | $5,597,000 | – | 78,001 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |